PDSB compared with GLIBA: revenue, margins and what each company keeps, and the suppliers and customers both name

PDSBPDS Biotechnology Corp

Mkt capRevenueRevenue

GLIBALiberty Capital Corp

Mkt capRevenueRevenue

Compare

PDSBPDS Biotechnology Corp

GLIBALiberty Capital Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PDSB: latest quarter not drawable.Method ›

PDSBPDS Biotechnology Corp

1.37· pre 1.37· delayed

Mkt cap$76.7MRevenue—

GLIBALiberty Capital Corp

23.02· pre 23.01· delayed

Pre-marketNov 3 '26delayed

Mkt cap$917.0MRevenue$261MQ2 FY26

Compare

Pre-marketNov 3 '26delayed

PDSBPDS Biotechnology Corp

GLIBALiberty Capital Corp

1.37pre 1.37delayed

Price

23.02pre 23.01delayed

$76.7M

Mkt cap

$917.0M

—

Revenue

$261MQ2 FY26

PDSB1.37vsGLIBA23.02Pre-marketNov 3 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PDSB 2

MRKMerckcustomer

—NCIunlistedsupplier

Shared 0

No disclosed counterparties: GLIBA.

Only GLIBA 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

PDSB, solidGLIBA, dashed